| Literature DB >> 33637692 |
Mengjia Li1,2, Penglei Jiang1,2, Kai Cheng1,2, Zehui Zhang1,2, Shuyu Lan1,2, Xiaoxia Li1,2, Lirong Zhao1,2, Yucheng Wang1,2, Xiang Wang3, Jing Chen1,2, Tao Ji1,2, Bingshe Han4,5, Junfang Zhang1,6.
Abstract
MYB plays vital roles in regulating proliferation and differentiation of hematopoietic progenitor cells, dysregulation of MYB has been implicated in the pathogenesis of leukemia. Although the transcription of MYB has been well studied, its detailed underlying regulatory mechanisms still remain elusive. Here, we detected the long-range interaction between the upstream regions, -34k and -88k, and the MYB promoter in K562, U937, and HL-60 cells using circularized chromosome conformation capture (4C) assay, which declined when MYB was downregulated during chemical-induced differentiation. The enrichment of enhancer markers, H3K4me1 and H3K27ac, and enhancer activity at the -34k and -88k regions were confirmed by ChIP-qPCR and luciferase assay respectively. ChIP-qPCR showed the dynamic binding of GATA1, TAL1, and CCAAT/enhancer-binding protein (C/EBPβ) at -34k and -88k during differentiation of K562 cells. Epigenome editing by a CRISPR-Cas9-based method showed that H3K27ac at -34k enhanced TF binding and MYB expression, while DNA methylation inhibited MYB expression. Taken together, our data revealed that enhancer elements at -34k are required for MYB expression, TF binding, and epigenetic modification are closely involved in this process in human myeloid leukemia cells.Entities:
Year: 2021 PMID: 33637692 PMCID: PMC7910426 DOI: 10.1038/s41419-021-03515-z
Source DB: PubMed Journal: Cell Death Dis Impact factor: 8.469